These MFSD12-expressing cells were significantly more abundant in the LIHC tumor core and edge than in nearby normal tissue, blood, or cholangiocarcinoma, indicating subtype-specific upregulation. The gene discussed is MFSD12; the disease is cholangiocarcinoma.